Biomerica, Inc.
BMRA
$0.5725
-$0.0315-5.22%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.58M | 5.51M | 5.41M | 5.41M | 5.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.58M | 5.51M | 5.41M | 5.41M | 5.50M |
| Cost of Revenue | 4.98M | 5.02M | 4.81M | 4.79M | 4.61M |
| Gross Profit | 597.00K | 485.00K | 608.00K | 617.00K | 886.00K |
| SG&A Expenses | 5.32M | 5.67M | 5.48M | 5.70M | 5.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.47M | 12.01M | 11.78M | 12.08M | 11.83M |
| Operating Income | -5.89M | -6.50M | -6.37M | -6.68M | -6.33M |
| Income Before Tax | -5.59M | -6.14M | -5.94M | -6.30M | -6.00M |
| Income Tax Expenses | 12.00K | 23.00K | 42.00K | 48.00K | 79.00K |
| Earnings from Continuing Operations | -5.61 | -6.16 | -5.98 | -6.35 | -6.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.61M | -6.16M | -5.98M | -6.35M | -6.08M |
| EBIT | -5.89M | -6.50M | -6.37M | -6.68M | -6.33M |
| EBITDA | -5.80M | -6.42M | -6.29M | -6.60M | -6.25M |
| EPS Basic | -0.33 | -0.37 | -0.36 | -0.38 | -0.39 |
| Normalized Basic EPS | -0.21 | -0.23 | -0.22 | -0.24 | -0.24 |
| EPS Diluted | -0.34 | -0.37 | -0.36 | -0.38 | -0.39 |
| Normalized Diluted EPS | -0.21 | -0.23 | -0.22 | -0.24 | -0.24 |
| Average Basic Shares Outstanding | 67.59M | 67.29M | 67.29M | 67.06M | 63.72M |
| Average Diluted Shares Outstanding | 67.59M | 67.29M | 67.29M | 67.06M | 63.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
